APO RESEARCH · REPORT
Recombinant Proteins
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Product & engineering
Understand the product.
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Selected research
Industry Growth & Trends
Global Recombinant Proteins Industry Growth and Trends Forecast to 2032
Market perspective
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
According to APO Research, the global Recombinant Proteins market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Recombinant Proteins market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Recombinant Proteins market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant Proteins market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant Proteins.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Recombinant Proteins market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Recombinant Proteins Market by Company
Abcam PLC
R&D Systems
Miltenyi Biotec
Thermo Fisher Scientific
Sigma Aldrich Company
GE Healthcare
Lonza
Merck KGaA
ProSpec Tany TechnoGene
Eurogentec (Kaneka Corporation)
PeproTech
BPS Bioscience
Reprocell
GenScript Biotech Corporation
Abnova Corporation
Recombinant Proteins Segment by Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Recombinant Proteins Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Recombinant Proteins Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Proteins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recombinant Proteins and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Proteins.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Recombinant Proteins companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Hormones
- Growth Factors
- Cytokines
- Plasma Protein Factor
- Recombinant Metabolic Enzymes
- Immune Checkpoint Regulators
- Others
Applications
- Biopharmaceutical Companies
- Academic and Research Institutes
- Contract Research Organizations
Companies covered
- Abcam PLC
- R&D Systems
- Miltenyi Biotec
- Thermo Fisher Scientific
- Sigma Aldrich Company
- GE Healthcare
- Lonza
- Merck KGaA
- ProSpec Tany TechnoGene
- Eurogentec (Kaneka Corporation)
- PeproTech
- BPS Bioscience
- Reprocell
- GenScript Biotech Corporation
- Abnova Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Recombinant Proteins Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Recombinant Proteins Market Size by Region (2021-2032)
- 1.4.1 Global Recombinant Proteins Market Size by Region (2021-2026)
- 1.4.2 Global Recombinant Proteins Market Size by Region (2027-2032)
- 1.5 Key Regions Recombinant Proteins Market Size (2021-2032)
- 1.5.1 North America Recombinant Proteins Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Recombinant Proteins Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Recombinant Proteins Market Size Growth Rate (2021-2032)
- 1.5.4 South America Recombinant Proteins Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Recombinant Proteins Market Size Growth Rate (2021-2032)
2 Recombinant Proteins Market by Type
- 2.1 Type Introduction
- 2.1.1 Hormones
- 2.1.2 Growth Factors
- 2.1.3 Cytokines
- 2.1.4 Plasma Protein Factor
- 2.1.5 Recombinant Metabolic Enzymes
- 2.1.6 Immune Checkpoint Regulators
- 2.1.7 Others
- 2.2 Global Recombinant Proteins Market Size by Type
- 2.2.1 Global Recombinant Proteins Market Size Overview by Type (2021-2032)
- 2.2.2 Global Recombinant Proteins Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Recombinant Proteins Market Size Forecasted by Type (2027-2032)
- 2.3 Global Recombinant Proteins Market Size by Regions
- 2.3.1 North America Recombinant Proteins Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Recombinant Proteins Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Recombinant Proteins Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Recombinant Proteins Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Recombinant Proteins Market Size Breakdown by Type (2021-2026)
3 Recombinant Proteins Market by Application
- 3.1 Type Introduction
- 3.1.1 Biopharmaceutical Companies
- 3.1.2 Academic and Research Institutes
- 3.1.3 Contract Research Organizations
- 3.2 Global Recombinant Proteins Market Size by Application
- 3.2.1 Global Recombinant Proteins Market Size Overview by Application (2021-2032)
- 3.2.2 Global Recombinant Proteins Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Recombinant Proteins Market Size Forecasted by Application (2027-2032)
- 3.3 Global Recombinant Proteins Market Size by Regions
- 3.3.1 North America Recombinant Proteins Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Recombinant Proteins Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Recombinant Proteins Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Recombinant Proteins Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Recombinant Proteins Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Recombinant Proteins Industry Trends
- 4.2 Recombinant Proteins Industry Drivers
- 4.3 Recombinant Proteins Industry Opportunities and Challenges
- 4.4 Recombinant Proteins Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Recombinant Proteins Revenue (2021-2026)
- 5.2 Global Recombinant Proteins Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Recombinant Proteins Key Company Headquarters & Area Served
- 5.4 Global Recombinant Proteins Company, Product Type & Application
- 5.5 Global Recombinant Proteins Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Recombinant Proteins Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Recombinant Proteins Players Market Share by Revenue in 2025
- 5.6.3 2025 Recombinant Proteins Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Abcam PLC
- 6.1.1 Abcam PLC Company Information
- 6.1.2 Abcam PLC Business Overview
- 6.1.3 Abcam PLC Recombinant Proteins Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Abcam PLC Recombinant Proteins Product Portfolio
- 6.1.5 Abcam PLC Recent Developments
- 6.2 R&D Systems
- 6.2.1 R&D Systems Company Information
- 6.2.2 R&D Systems Business Overview
- 6.2.3 R&D Systems Recombinant Proteins Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 R&D Systems Recombinant Proteins Product Portfolio
- 6.2.5 R&D Systems Recent Developments
- 6.3 Miltenyi Biotec
- 6.3.1 Miltenyi Biotec Company Information
- 6.3.2 Miltenyi Biotec Business Overview
- 6.3.3 Miltenyi Biotec Recombinant Proteins Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Miltenyi Biotec Recombinant Proteins Product Portfolio
- 6.3.5 Miltenyi Biotec Recent Developments
- 6.4 Thermo Fisher Scientific
- 6.4.1 Thermo Fisher Scientific Company Information
- 6.4.2 Thermo Fisher Scientific Business Overview
- 6.4.3 Thermo Fisher Scientific Recombinant Proteins Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Thermo Fisher Scientific Recombinant Proteins Product Portfolio
- 6.4.5 Thermo Fisher Scientific Recent Developments
- 6.5 Sigma Aldrich Company
- 6.5.1 Sigma Aldrich Company Company Information
- 6.5.2 Sigma Aldrich Company Business Overview
- 6.5.3 Sigma Aldrich Company Recombinant Proteins Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Sigma Aldrich Company Recombinant Proteins Product Portfolio
- 6.5.5 Sigma Aldrich Company Recent Developments
- 6.6 GE Healthcare
- 6.6.1 GE Healthcare Company Information
- 6.6.2 GE Healthcare Business Overview
- 6.6.3 GE Healthcare Recombinant Proteins Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 GE Healthcare Recombinant Proteins Product Portfolio
- 6.6.5 GE Healthcare Recent Developments
- 6.7 Lonza
- 6.7.1 Lonza Company Information
- 6.7.2 Lonza Business Overview
- 6.7.3 Lonza Recombinant Proteins Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Lonza Recombinant Proteins Product Portfolio
- 6.7.5 Lonza Recent Developments
- 6.8 Merck KGaA
- 6.8.1 Merck KGaA Company Information
- 6.8.2 Merck KGaA Business Overview
- 6.8.3 Merck KGaA Recombinant Proteins Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Merck KGaA Recombinant Proteins Product Portfolio
- 6.8.5 Merck KGaA Recent Developments
- 6.9 ProSpec Tany TechnoGene
- 6.9.1 ProSpec Tany TechnoGene Company Information
- 6.9.2 ProSpec Tany TechnoGene Business Overview
- 6.9.3 ProSpec Tany TechnoGene Recombinant Proteins Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 ProSpec Tany TechnoGene Recombinant Proteins Product Portfolio
- 6.9.5 ProSpec Tany TechnoGene Recent Developments
- 6.10 Eurogentec (Kaneka Corporation)
- 6.10.1 Eurogentec (Kaneka Corporation) Company Information
- 6.10.2 Eurogentec (Kaneka Corporation) Business Overview
- 6.10.3 Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Eurogentec (Kaneka Corporation) Recombinant Proteins Product Portfolio
- 6.10.5 Eurogentec (Kaneka Corporation) Recent Developments
- 6.11 PeproTech
- 6.11.1 PeproTech Company Information
- 6.11.2 PeproTech Business Overview
- 6.11.3 PeproTech Recombinant Proteins Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 PeproTech Recombinant Proteins Product Portfolio
- 6.11.5 PeproTech Recent Developments
- 6.12 BPS Bioscience
- 6.12.1 BPS Bioscience Company Information
- 6.12.2 BPS Bioscience Business Overview
- 6.12.3 BPS Bioscience Recombinant Proteins Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 BPS Bioscience Recombinant Proteins Product Portfolio
- 6.12.5 BPS Bioscience Recent Developments
- 6.13 Reprocell
- 6.13.1 Reprocell Company Information
- 6.13.2 Reprocell Business Overview
- 6.13.3 Reprocell Recombinant Proteins Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Reprocell Recombinant Proteins Product Portfolio
- 6.13.5 Reprocell Recent Developments
- 6.14 GenScript Biotech Corporation
- 6.14.1 GenScript Biotech Corporation Company Information
- 6.14.2 GenScript Biotech Corporation Business Overview
- 6.14.3 GenScript Biotech Corporation Recombinant Proteins Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 GenScript Biotech Corporation Recombinant Proteins Product Portfolio
- 6.14.5 GenScript Biotech Corporation Recent Developments
- 6.15 Abnova Corporation
- 6.15.1 Abnova Corporation Company Information
- 6.15.2 Abnova Corporation Business Overview
- 6.15.3 Abnova Corporation Recombinant Proteins Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Abnova Corporation Recombinant Proteins Product Portfolio
- 6.15.5 Abnova Corporation Recent Developments
7 North America
- 7.1 North America Recombinant Proteins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Recombinant Proteins Market Size by Country (2021-2026)
- 7.3 North America Recombinant Proteins Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Recombinant Proteins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Recombinant Proteins Market Size by Country (2021-2026)
- 8.3 Europe Recombinant Proteins Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Recombinant Proteins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Recombinant Proteins Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Recombinant Proteins Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Recombinant Proteins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Recombinant Proteins Market Size by Country (2021-2026)
- 10.3 South America Recombinant Proteins Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Recombinant Proteins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Recombinant Proteins Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Recombinant Proteins Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst